These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33487517)

  • 1. Justice community opioid innovation network (JCOIN): The TCU research hub.
    Knight D; Becan J; Olson D; Davis NP; Jones J; Wiese A; Carey P; Howell D; Knight K
    J Subst Abuse Treat; 2021 Sep; 128():108290. PubMed ID: 33487517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kentucky Women's Justice Community Opioid Innovation Network (JCOIN): A type 1 effectiveness-implementation hybrid trial to increase utilization of medications for opioid use disorder among justice-involved women.
    Staton M; Webster JM; Leukefeld C; Tillson M; Marks K; Oser C; Bush HM; Fanucchi L; Fallin-Bennett A; Garner BR; McCollister K; Johnson S; Winston E
    J Subst Abuse Treat; 2021 Sep; 128():108284. PubMed ID: 33455828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engaging the justice system to address the opioid crisis: The Justice Community Opioid Innovation Network (JCOIN).
    Ducharme LJ; Wiley TRA; Mulford CF; Su ZI; Zur JB
    J Subst Abuse Treat; 2021 Sep; 128():108307. PubMed ID: 33531212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economic analyses of the justice community opioid innovation network (JCOIN).
    Murphy SM; Laiteerapong N; Pho MT; Ryan D; Montoya I; Shireman TI; Huang E; McCollister KE
    J Subst Abuse Treat; 2021 Sep; 128():108262. PubMed ID: 33419602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).
    Evans EA; Stopka TJ; Pivovarova E; Murphy SM; Taxman FS; Ferguson WJ; Bernson D; Santelices C; McCollister KE; Hoskinson R; Lincoln T; Friedmann PD;
    J Subst Abuse Treat; 2021 Sep; 128():108275. PubMed ID: 33483222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons.
    Springer SA; Nijhawan AE; Knight K; Kuo I; Di Paola A; Schlossberg E; Frank CA; Sanchez M; Pankow J; Proffitt RP; Lehman W; Pulitzer Z; Thompson K; Violette S; Harding KK;
    BMC Infect Dis; 2022 Apr; 22(1):380. PubMed ID: 35428213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing interagency collaboration to address the opioid epidemic: A scoping review of joint criminal justice and healthcare initiatives.
    Yatsco AJ; Champagne-Langabeer T; Holder TF; Stotts AL; Langabeer JR
    Int J Drug Policy; 2020 Sep; 83():102849. PubMed ID: 32653668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing contingency management for stimulant use in opioid treatment programs: protocol of a type III hybrid effectiveness-stepped-wedge trial.
    Becker SJ; DiClemente-Bosco K; Scott K; Janssen T; Salino SM; Hasan FN; Yap KR; Garner BR
    Implement Sci; 2023 Sep; 18(1):41. PubMed ID: 37705093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for a quasi-experimental, 950 county study examining implementation outcomes and mechanisms of Stepping Up, a national policy effort to improve mental health and substance use services for justice-involved individuals.
    Johnson JE; Viglione J; Ramezani N; Cuellar AE; Hailemariam M; Rosen R; Breno A; Taxman FS
    Implement Sci; 2021 Mar; 16(1):31. PubMed ID: 33781294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing Opioid Mortality in Illinois (ROMI): A case management/peer recovery coaching critical time intervention clinical trial protocol.
    Pho M; Erzouki F; Boodram B; Jimenez AD; Pineros J; Shuman V; Claypool EJ; Bouris AM; Gastala N; Reichert J; Kelly M; Salisbury-Afshar E; Epperson MW; Gibbons RD; Schneider JA; Pollack HA
    J Subst Abuse Treat; 2021 Sep; 128():108348. PubMed ID: 33745757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stepped-wedge randomized controlled trial of a novel opioid court to improve identification of need and linkage to medications for opioid use disorder treatment for court-involved adults.
    Elkington KS; Nunes E; Schachar A; Ryan ME; Garcia A; Van DeVelde K; Reilly D; O'Grady M; Williams AR; Tross S; Wilson P; Cohall R; Cohall A; Wainberg M
    J Subst Abuse Treat; 2021 Sep; 128():108277. PubMed ID: 33487516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using implementation interventions and peer recovery support to improve opioid treatment outcomes in community supervision: Protocol.
    Martin RA; Stein LAR; Rohsenow DJ; Belenko S; Hurley LE; Clarke JG; Brinkley-Rubinstein L
    J Subst Abuse Treat; 2021 Sep; 128():108364. PubMed ID: 33741216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile Justice-Translational Research on Interventions for Adolescents in the Legal System (JJ-TRIALS): a cluster randomized trial targeting system-wide improvement in substance use services.
    Knight DK; Belenko S; Wiley T; Robertson AA; Arrigona N; Dennis M; Bartkowski JP; McReynolds LS; Becan JE; Knudsen HK; Wasserman GA; Rose E; DiClemente R; Leukefeld C;
    Implement Sci; 2016 Apr; 11():57. PubMed ID: 27130175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Agonist Treatment Recipients within Criminal Justice-Involved Populations.
    Guastaferro WP; Koetzle D; Lutgen-Nieves L; Teasdale B
    Subst Use Misuse; 2022; 57(5):698-707. PubMed ID: 35172673
    [No Abstract]   [Full Text] [Related]  

  • 17. Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial.
    Becker SJ; Murphy CM; Hartzler B; Rash CJ; Janssen T; Roosa M; Madden LM; Garner BR
    Addict Sci Clin Pract; 2021 Oct; 16(1):61. PubMed ID: 34635178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for community-driven selection of strategies to implement evidence-based practices to reduce opioid overdoses in the HEALing Communities Study: a trial to evaluate a community-engaged intervention in Kentucky, Massachusetts, New York and Ohio.
    Young AM; Brown JL; Hunt T; Sprague Martinez LS; Chandler R; Oga E; Winhusen TJ; Baker T; Battaglia T; Bowers-Sword R; Button A; Fallin-Bennett A; Fanucchi L; Freeman P; Glasgow LM; Gulley J; Kendell C; Lofwall M; Lyons MS; Quinn M; Rapkin BD; Surratt HL; Walsh SL
    BMJ Open; 2022 Sep; 12(9):e059328. PubMed ID: 36123106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.
    Grella CE; Ostile E; Scott CK; Dennis M; Carnavale J
    Int J Drug Policy; 2020 Jul; 81():102768. PubMed ID: 32446130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study.
    Finlay AK; Morse E; Stimmel M; Taylor E; Timko C; Harris AHS; Smelson D; Yu M; Blue-Howells J; Binswanger IA
    J Gen Intern Med; 2020 Sep; 35(9):2529-2536. PubMed ID: 32583337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.